- A Case of Vibrio cholerae Non-O1/O139 Gastroenteritis
-
Lee HK, Shin OR, Lee DG, Chae HS, Kim JT, Kang CS
- KMID: 2143208
- Korean J Lab Med.
- 2004 Dec;24(6):386-388.
Vibrio cholerae non-O1/O139 strains are the organisms that are biochemically indistinguishable from V. cholerae but do not agglutinate in Vibrio cholerae O1 and O139 antisera. V. cholerae non-O1/O139 strains are... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic Characteristics and Relatedness of Imported Vibrio cholerae O1 Biotype El Tor in Korea
-
Kim H, Jeon S, Kim J, Kim S, Lee DY
- KMID: 2169599
- Ann Clin Microbiol.
- 2013 Mar;16(1):25-32.
- doi: 10.5145/ACM.2013.16.1.25
BACKGROUND: Cholera is a representative water-borne disease that is caused by V. cholera ctx (+). V. cholera El Tor was previously the primary pathogen, but after the seventh pandemic outbreak,... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
-
Baik YO, Choi SK, Kim JW, Yang JS, Kim IY, Kim CW, Hong JH
- KMID: 1774453
- J Korean Med Sci.
- 2014 Apr;29(4):494-501.
- doi: 10.3346/jkms.2014.29.4.494
The safety, tolerability and immunogenicity of an oral cholera vaccine (OCV) was assessed in adult Korean male through an open-label, non-comparative clinical study. Two doses of vaccine with an interval... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
-
Lee EY, Lee S, Rho S, Kim JO, Choi SK, Lee YJ, Park JY, Song M, Yang JS
- KMID: 2418088
- Clin Exp Vaccine Res.
- 2018 Jul;7(2):104-110.
- doi: 10.7774/cevr.2018.7.2.104
PURPOSE: An oral cholera vaccine (OCV), Euvichol, with thimerosal (TM) as preservative, was prequalified by the World Health Organization (WHO) in 2015. In recent years, public health services and regulatory... -
- CITED
-
- Close
- SHARE
-
- Close
